INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

M&T Bank Corp's Holding History (CIK: 0000036270)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 4,061 Value ($000) $536 Avg Close Range
Q4 2024
Shares 6,301 Value ($000) $526 Avg Close Range
Q3 2024
Shares 6,163 Value ($000) $451 Avg Close Range
Q2 2024
Shares 4,521 Value ($000) $310 Avg Close Range
Q1 2024
Shares 4,398 Value ($000) $304 Avg Close Range
Q4 2023
Shares 4,780 Value ($000) $342 Avg Close Range
Q3 2023
Shares 4,006 Value ($000) $209 Avg Close Range
Q2 2023
Shares 5,174 Value ($000) $327 Avg Close Range
Q1 2023
Shares 5,643 Value ($000) $305 Avg Close Range
Q4 2022
Shares 6,218 Value ($000) $329 Avg Close Range
Q3 2022
Shares 5,888 Value ($000) $274 Avg Close Range
Q2 2022
Shares 3,692 Value ($000) $211 Avg Close Range
Q1 2022
Shares 5,252 Value ($000) $322 Avg Close Range
Q4 2021
Shares 6,804 Value ($000) $356 Avg Close Range
Q3 2021
Shares 6,722 Value ($000) $251 Avg Close Range
Q2 2021
Shares 7,271 Value ($000) $297 Avg Close Range
Q1 2021
Shares 7,015 Value ($000) $239 Avg Close Range
Q4 2020
Shares 10,953 Value ($000) $348 Avg Close Range
Q3 2020
Shares 20,176 Value ($000) $518 Avg Close Range
Q2 2020
Shares 17,105 Value ($000) $439 Avg Close Range
Q1 2020
Shares 11,736 Value ($000) $180 Avg Close Range
Q3 2015
Shares 8,250 Value ($000) $330 Avg Close Range